Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mavligit

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Journal of the National Cancer Institute|October 1, 1973
Brief communication: Specific colony inhibition by human lymphoma cells on an established human lymphoma cell lineB Drewinko, G Mavligit, U Ambus, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1985
Arterial infusion of dacarbazine and cisplatin for recurrent regionally confined melanomaD B Frost, Y Z Patt, G Mavligit, et al.
The American Journal of Medicine|August 1, 1983
Effective retreatment of patients with colorectal cancer and liver metastasesY Z Patt, R E Peters, V P Chuang, et al.
Hamatologie Und Bluttransfusion|January 1, 1974
Human immune response to Rauscher leukemia virusE M Hersh, J U Gutterman, G Mavligit, et al.
International Journal of Cancer|October 23, 1997
Secondary drug resistance in breast cancer: failure to reverse with oral nifedipineF A Holmes, A Lopez, G Mavligit, et al.
International Journal of Cancer|May 1, 1973
Auto-immunization with acute leukemia cells: demonstration of increased lymphocyte responsivenessJ U Gutterman, G Mavligit, K B McCredie, et al.
Journal of Immunological Methods|July 15, 1983
Objective evaluation of local xenogeneic graft-versus-host reaction by computerized radioisotope imaging (CRI)M Talpaz, E Kim, M Guardini, et al.
Cancer|November 1, 1985
Palliation of pelvic recurrence of colorectal cancer with intra-arterial 5-fluorouracil and mitomycinY Z Patt, R E Peters, V P Chuang, et al.
The American Journal of Medicine|June 1, 1995
Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosisZ Estrov, M Talpaz, G Mavligit, et al.
Lancet (London, England)|June 2, 1973
Active immunotherapy with B.C.G. for recurrent malignant melanomaJ U Gutterman, G Mavligit, C McBride, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Journal of the National Cancer Institute|October 1, 1973
Brief communication: Specific colony inhibition by human lymphoma cells on an established human lymphoma cell lineB Drewinko, G Mavligit, U Ambus, et al.
Archives of Surgery (Chicago, Ill. : 1960)|April 1, 1985
Arterial infusion of dacarbazine and cisplatin for recurrent regionally confined melanomaD B Frost, Y Z Patt, G Mavligit, et al.
The American Journal of Medicine|August 1, 1983
Effective retreatment of patients with colorectal cancer and liver metastasesY Z Patt, R E Peters, V P Chuang, et al.
Hamatologie Und Bluttransfusion|January 1, 1974
Human immune response to Rauscher leukemia virusE M Hersh, J U Gutterman, G Mavligit, et al.
International Journal of Cancer|October 23, 1997
Secondary drug resistance in breast cancer: failure to reverse with oral nifedipineF A Holmes, A Lopez, G Mavligit, et al.
International Journal of Cancer|May 1, 1973
Auto-immunization with acute leukemia cells: demonstration of increased lymphocyte responsivenessJ U Gutterman, G Mavligit, K B McCredie, et al.
Journal of Immunological Methods|July 15, 1983
Objective evaluation of local xenogeneic graft-versus-host reaction by computerized radioisotope imaging (CRI)M Talpaz, E Kim, M Guardini, et al.
Cancer|November 1, 1985
Palliation of pelvic recurrence of colorectal cancer with intra-arterial 5-fluorouracil and mitomycinY Z Patt, R E Peters, V P Chuang, et al.
The American Journal of Medicine|June 1, 1995
Elevated plasma thrombopoietic activity in patients with metastatic cancer-related thrombocytosisZ Estrov, M Talpaz, G Mavligit, et al.
Lancet (London, England)|June 2, 1973
Active immunotherapy with B.C.G. for recurrent malignant melanomaJ U Gutterman, G Mavligit, C McBride, et al.
Pageof 5